2Jones JF, Shurin S, Abramowsky C, et al. T-cell lymphonms containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection. N Engl J Med, 1988,318:733.
3Jooryung H, Kwanghyun C, Dae SH, et al. Detection of Epstein-Barr virus in Korean peripheral T-cell lymphoma. Am J Hematol, 1999, 60:205-214.
4Hirose Y,Massaki Y,Sasski K,et al.Determination of EBV association with B-cell lymphomas in Japan:study of 72 cases in situ hybrdization,PCR,ICH studies.Int J Hematol,1998,67:165-174
5Harris NL, Jaffe ES, Stein H, et al. A Revised European-American classification of lymphoid neoplasms: a proposal from the International lymphoma study group. Blood, 1994,84 : 1361-1392.
6Clemens M.I. The small RNAs of Epstein-Barr virus. Mol Biol Rep, 1993,17:81-92.
7De-Bruin P,Jiwa M,Oudejans JJ,et al. Presenee of Epstein-Barr virus in estranodal T cell lymphoma: differences in relation to site. Blood, 1994,83 : 1612-1618.
8Ko YH, Kim CW, Park CS, et al. Real classification of malignant lymphomas in the Republic of Korea. Incidence of recently recognized entities and changes in clinicopathologic features. Cancer, 1998,83 : 806-812.
9Guam M, Gaetano R, Earl EH. Epstein-Barr virus ( EBV ) induced long-term proliferation of CD4^+ lymphocytes leading to T lymphoblastoid cell lines carrying EBV. Anticancer Res, 1999,19 : 3007-3018.
10Warty D,Hedrick JA,Siervo S, et al. Infection of human thymocytes by Epstein-Barr virus.J Exp Med, 1991,173:971-980.
8Takeuchi K, Tanaka-Taya K, Kazuyama Y, Ito YM, Hashimoto S, Fukayama M, et al. Prevalence of Epstein-Barr vires in Japan: trends and future prediction[ J ]. Pathol Int, 2006, 56 (3) : 112- 116.
9Okan M. Overview and problematic standpoints of severe chronic active Epstein Barr virusint-ction syndrome [ J]. Crit Rev Oncol Hematol, 2002, 44(3): 273-282.
10Heller KN, Steinherz PG, Portlock CS, et al. EBV-positive lym- phoma patients have a selective deficiency in EBV immunity[J]. J Cein Oncol,2009,32(16) :233-235.
